99 related articles for article (PubMed ID: 30577572)
1. Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice.
Wei Y; Chhiba KD; Zhang F; Ye X; Wang L; Zhang L; Robida PA; Moreno-Vinasco L; Schnaar RL; Roers A; Hartmann K; Lee CM; Demers D; Zheng T; Bochner BS; Zhu Z
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577572
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI-Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge.
Duan S; Arlian BM; Nycholat CM; Wei Y; Tateno H; Smith SA; Macauley MS; Zhu Z; Bochner BS; Paulson JC
J Immunol; 2021 May; 206(10):2290-2300. PubMed ID: 33911007
[TBL] [Abstract][Full Text] [Related]
3. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
4. Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells.
Robida PA; Rische CH; Morgenstern NB; Janarthanam R; Cao Y; Krier-Burris RA; Korver W; Xu A; Luu T; Schanin J; Leung J; Rothenberg ME; Wechsler JB; Youngblood BA; Bochner BS; O'Sullivan JA
Cells; 2022 Mar; 11(7):. PubMed ID: 35406705
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation.
Kano G; Almanan M; Bochner BS; Zimmermann N
J Allergy Clin Immunol; 2013 Aug; 132(2):437-45. PubMed ID: 23684072
[TBL] [Abstract][Full Text] [Related]
6. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
[TBL] [Abstract][Full Text] [Related]
7. Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death
Carroll DJ; Cao Y; Bochner BS; O'Sullivan JA
Front Immunol; 2021; 12():737988. PubMed ID: 34721399
[TBL] [Abstract][Full Text] [Related]
8. Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells.
Cao Y; Rische CH; Bochner BS; O'Sullivan JA
Front Immunol; 2023; 14():1283370. PubMed ID: 37928558
[TBL] [Abstract][Full Text] [Related]
9. Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls.
Knuplez E; Krier-Burris R; Cao Y; Marsche G; O'Sullivan J; Bochner BS
J Leukoc Biol; 2020 Jul; 108(1):43-58. PubMed ID: 32134149
[TBL] [Abstract][Full Text] [Related]
10. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.
Jia Y; Yu H; Fernandes SM; Wei Y; Gonzalez-Gil A; Motari MG; Vajn K; Stevens WW; Peters AT; Bochner BS; Kern RC; Schleimer RP; Schnaar RL
J Allergy Clin Immunol; 2015 Mar; 135(3):799-810.e7. PubMed ID: 25747723
[TBL] [Abstract][Full Text] [Related]
11. Siglec-9 is an inhibitory receptor on human mast cells in vitro.
Miralda I; Samanas NB; Seo AJ; Foronda JS; Sachen J; Hui Y; Morrison SD; Oskeritzian CA; Piliponsky AM
J Allergy Clin Immunol; 2023 Sep; 152(3):711-724.e14. PubMed ID: 37100120
[TBL] [Abstract][Full Text] [Related]
12. Global microRNA expression is essential for murine mast cell development in vivo.
Oh SY; Brandal S; Kapur R; Zhu Z; Takemoto CM
Exp Hematol; 2014 Oct; 42(10):919-23.e1. PubMed ID: 25201754
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8.
Korver W; Benet Z; Wong A; Negri GL; Chang K; Sanchez R; Leung J; De Freitas N; Luu T; Schanin J; Youngblood BA
Allergy; 2024 Mar; 79(3):629-642. PubMed ID: 38186079
[TBL] [Abstract][Full Text] [Related]
14. Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia.
Nunes J; Tafesse R; Mao C; Purcell M; Mo X; Zhang L; Long M; Cyr MG; Rader C; Muthusamy N
Nat Commun; 2024 Jun; 15(1):5180. PubMed ID: 38890323
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil and mast cell Siglecs: From biology to drug target.
O'Sullivan JA; Chang AT; Youngblood BA; Bochner BS
J Leukoc Biol; 2020 Jul; 108(1):73-81. PubMed ID: 31965606
[TBL] [Abstract][Full Text] [Related]
16. Supplementing Glucose Intake Reverses the Inflammation Induced by a High-Fat Diet by Increasing the Expression of Siglec-E Ligands on Erythrocytes.
Liu H; Li J; Wu N; She Y; Luo Y; Huang Y; Quan H; Fu W; Li X; Zeng D; Jia Y
Inflammation; 2024 Apr; 47(2):609-625. PubMed ID: 38448631
[TBL] [Abstract][Full Text] [Related]
17. Activity-dependent FosB gene expression negatively regulates mast cell functions.
Duque-Wilckens N; Maradiaga N; Szu-Ying Y; Joseph D; Srinavasan V; Thelen K; Sotomayor F; Durga K; Nestler E; Moeser AJ; Robison AJ
bioRxiv; 2024 May; ():. PubMed ID: 38766119
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils disrupt B-1a cell homeostasis by targeting Siglec-G to exacerbate sepsis.
Tan C; Reilly B; Ma G; Murao A; Jha A; Aziz M; Wang P
Cell Mol Immunol; 2024 May; ():. PubMed ID: 38789529
[TBL] [Abstract][Full Text] [Related]
19. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
Youngblood BA; Brock EC; Leung J; Falahati R; Bochner BS; Rasmussen HS; Peterson K; Bebbington C; Tomasevic N
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465299
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.
Lübbers J; Rodríguez E; van Kooyk Y
Front Immunol; 2018; 9():2807. PubMed ID: 30581432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
